GKOS - Glaukos Corporation
NYSE
->
Healthcare
->
Medical Instruments & Supplies
San Clemente,
United States
Type: Equity
GKOS price evolution
GKOS
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $99.32 | $114.78 | $100.67 | $83.48 |
| Short term investments | $201.96 | $191.93 | $209 | $241.37 |
| Net receivables | $39.85 | $39.33 | $39.25 | $37.85 |
| Inventory | $41.99 | $39.78 | $39.45 | $40.45 |
| Total current assets | $395.46 | $399.53 | $401.26 | $415.88 |
| Long term investments | ||||
| Property, plant & equipment | $174.54 | $175.13 | $175.79 | $170.97 |
| Goodwill & intangible assets | $349.09 | $355.32 | $361.55 | $367.77 |
| Total noncurrent assets | $544.95 | $549.11 | $555.48 | $556.71 |
| Total investments | $201.96 | $191.93 | $209 | $241.37 |
| Total assets | $940.41 | $948.63 | $956.74 | $972.59 |
| Current liabilities | ||||
| Accounts payable | $13.44 | $10.41 | $8.56 | $12.03 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $74.01 | $67.15 | $63.89 | $62.39 |
| Long term debt | $383.74 | $383.79 | $383.88 | $383.24 |
| Total noncurrent liabilities | $404.63 | $403.83 | $404.04 | $401.69 |
| Total debt | $383.74 | $383.79 | $383.88 | $383.24 |
| Total liabilities | $478.65 | $470.98 | $467.93 | $464.08 |
| Shareholders' equity | ||||
| Retained earnings | -$599.07 | -$562.29 | -$531.84 | -$499.03 |
| Other shareholder equity | $1.17 | $0.76 | -$0.39 | -$1.32 |
| Total shareholder equity | $461.77 | $477.66 | $488.81 | $508.51 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $99.32 | $126.6 | $110.12 | $106.16 |
| Short term investments | $201.96 | $233.17 | $313.34 | $307.77 |
| Net receivables | $39.85 | $36.07 | $33.44 | $36.06 |
| Inventory | $41.99 | $37.84 | $23.01 | $15.81 |
| Total current assets | $395.46 | $443.86 | $486.13 | $469.44 |
| Long term investments | ||||
| Property, plant & equipment | $174.54 | $166.83 | $146.13 | $95.46 |
| Goodwill & intangible assets | $349.09 | $374 | $398.92 | $423.83 |
| Total noncurrent assets | $544.95 | $558.52 | $563.57 | $536.06 |
| Total investments | $201.96 | $233.17 | $313.34 | $307.77 |
| Total assets | $940.41 | $1002.38 | $1049.7 | $1005.5 |
| Current liabilities | ||||
| Accounts payable | $13.44 | $14.4 | $7.33 | $4.37 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $74.01 | $72.36 | $63.36 | $49.7 |
| Long term debt | $383.74 | $353.57 | $382.38 | $270.81 |
| Total noncurrent liabilities | $404.63 | $400.02 | $399.19 | $288.35 |
| Total debt | $383.74 | $382.48 | $382.38 | $270.81 |
| Total liabilities | $478.65 | $472.38 | $462.55 | $338.05 |
| Shareholders' equity | ||||
| Retained earnings | -$599.07 | -$464.41 | -$365.21 | -$310.06 |
| Other shareholder equity | $1.17 | -$2.98 | $0.01 | $1 |
| Total shareholder equity | $461.77 | $530 | $587.15 | $667.45 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $82.36 | $78.05 | $80.4 | $73.9 |
| Cost of revenue | $18.89 | $18.51 | $20.1 | $18.07 |
| Gross Profit | $63.47 | $59.54 | $60.3 | $55.83 |
| Operating activities | ||||
| Research & development | $37.06 | $33.3 | $33.23 | $35.17 |
| Selling, general & administrative | $63.03 | $54.25 | $53.14 | $53.65 |
| Total operating expenses | $102.1 | $87.55 | $89.37 | $88.82 |
| Operating income | -$38.62 | -$28.01 | -$29.07 | -$32.99 |
| Income from continuing operations | ||||
| EBIT | -$33.29 | -$27.01 | -$28.98 | -$30.82 |
| Income tax expense | $0.06 | $0.04 | $0.43 | $0.4 |
| Interest expense | $3.43 | $3.4 | $3.4 | $3.41 |
| Net income | ||||
| Net income | -$36.78 | -$30.44 | -$32.81 | -$34.63 |
| Income (for common shares) | -$36.78 | -$30.44 | -$32.81 | -$34.63 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $314.71 | $282.86 | $294.01 | $224.96 |
| Cost of revenue | $75.58 | $68.98 | $66.63 | $91.72 |
| Gross Profit | $239.14 | $213.88 | $227.38 | $133.24 |
| Operating activities | ||||
| Research & development | $138.77 | $123.27 | $101 | $85.39 |
| Selling, general & administrative | $224.07 | $192.93 | $179.26 | $171.4 |
| Total operating expenses | $367.84 | $296.2 | $260.26 | $256.79 |
| Operating income | -$128.7 | -$82.31 | -$32.87 | -$123.55 |
| Income from continuing operations | ||||
| EBIT | -$120.09 | -$84.71 | -$35.9 | -$118.2 |
| Income tax expense | $0.93 | $0.77 | $0.33 | -$11.97 |
| Interest expense | $13.63 | $13.72 | $13.37 | $14.12 |
| Net income | ||||
| Net income | -$134.66 | -$99.19 | -$49.59 | -$120.35 |
| Income (for common shares) | -$134.66 | -$99.19 | -$49.59 | -$120.35 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$36.78 | -$30.44 | -$32.81 | -$34.63 |
| Operating activities | ||||
| Depreciation | $9.62 | $9.49 | $9.52 | $9.34 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $12.99 | $10.48 | $9.87 | $10.18 |
| Total cash flows from operations | -$10.66 | -$8.17 | -$8.16 | -$30.76 |
| Investing activities | ||||
| Capital expenditures | -$4.21 | -$3.36 | -$5.77 | -$6.91 |
| Investments | -$7.68 | $18.35 | $33.24 | -$6.39 |
| Total cash flows from investing | -$12.92 | $14.9 | $25.95 | -$13.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.12 | $8.43 | $1.64 | $2.84 |
| Net borrowings | -$0.19 | -$0.19 | -$0.18 | -$0.15 |
| Total cash flows from financing | $7.3 | $7.47 | -$0.88 | $1.15 |
| Effect of exchange rate | $0.82 | -$0.08 | $0.28 | $0.32 |
| Change in cash and equivalents | -$15.46 | $14.12 | $17.19 | -$43.13 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$134.66 | -$99.19 | -$49.59 | -$120.35 |
| Operating activities | ||||
| Depreciation | $37.98 | $35.95 | $34.42 | $34.61 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $43.53 | $38.56 | $30.15 | $43.3 |
| Total cash flows from operations | -$57.76 | -$33.08 | $24.71 | -$22.99 |
| Investing activities | ||||
| Capital expenditures | -$20.25 | -$30.11 | -$47.78 | -$6.93 |
| Investments | $37.51 | $75.9 | -$8.37 | -$196.31 |
| Total cash flows from investing | $14.1 | $44.78 | -$58.23 | -$205.06 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $19.03 | $9.21 | $30.94 | $24.22 |
| Net borrowings | -$0.71 | -$0.53 | -$0.66 | $242.21 |
| Total cash flows from financing | $15.04 | $6.25 | $39.26 | $262.54 |
| Effect of exchange rate | $1.34 | -$1.47 | -$1.77 | -$0.09 |
| Change in cash and equivalents | -$27.28 | $16.48 | $3.96 | $34.41 |
News
Fundamentals
| Market cap | $4.76B |
|---|---|
| Enterprise value | $5.04B |
| Shares outstanding | 49.12M |
| Revenue | $314.71M |
|---|---|
| EBITDA | -$82.12M |
| EBIT | -$120.09M |
| Net Income | -$134.66M |
| Revenue Q/Q | 15.64% |
| Revenue Y/Y | N/A |
| P/E ratio | -35.34 |
|---|---|
| EV/Sales | 16.03 |
| EV/EBITDA | -61.42 |
| EV/EBIT | -42.00 |
| P/S ratio | 15.12 |
| P/B ratio | 10.33 |
| Book/Share | 9.38 |
| Cash/Share | 2.02 |
| EPS | -$2.74 |
|---|---|
| ROA | -14.11% |
| ROE | -27.81% |
| Debt/Equity | 1.04 |
|---|---|
| Net debt/EBITDA | -4.62 |
| Current ratio | 5.34 |
| Quick ratio | 4.78 |